Travoprost Intraocular Implant + iStent Infinite

Recruiting now · Phase 4 · Has a placebo group

Conditions studied: Glaucoma, Open-Angle

In brief

Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.

Key facts

Study ID

NCT06066645

Run by

Glaukos Corporation

People needed

150

Starts

2023-09-14

Expected to finish

2028-02-01

Last updated by the study team

2026-06-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• diagnosis of open-angle glaucoma or ocular hypertension
• qualifying IOP in the study eye

You may not qualify if…

• unmedicated (washed out) IOP of >36 mmHg in the study eye
• hypersensitivity to travoprost or any other components of the travoprost intraocular implant
• vertical cup/disc ratio > 0.8 in the study eye
• best spectacle corrected visual acuity of worse than 20/80 in either eye
• any ocular disease or condition that, in the opinion of the investigator, may put the subject at significant risk, may confound the study results, or may interfere significantly with the subject's participation in the study

Where it is running

• Glaukos Clinical Study Site — Oklahoma City, Oklahoma, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.